Around 8 million people in the United States rely on insulin to manage their diabetes, but steady price increases have made the life-saving medicine increasingly more difficult to afford. CEO Cameron Owen says his company has created novel strains of bacteria that can produce insulin at twice the yield than is currently possible. A 2020 estimate by the RAND Corporation …
